Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy: A Subgroup Analysis of a Randomized Trial

K.W. Mahaffey; D. Wojdyla; Graeme Hankey; H.D. White; C.C. Nessel; J.P. Piccini; M.R. Patel; S.D. Berkowitz; R.C. Becker; J.L. Halperin; D.E. Singer; R.M. Califf; K.A.A. Fox; G. Breithardt; W. Hacke

doi:10.7326/0003-4819-158-12-201306180-00003

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy: A Subgroup Analysis of a Randomized Trial

K.W. Mahaffey, D. Wojdyla, Graeme Hankey, H.D. White, C.C. Nessel, J.P. Piccini, M.R. Patel, S.D. Berkowitz, R.C. Becker, J.L. Halperin, D.E. Singer, R.M. Califf, K.A.A. Fox, G. Breithardt, W. Hacke

Research output: Contribution to journal › Article › peer-review

48 Citations (Scopus)

Original language	English
Pages (from-to)	861-868
Journal	Annals of Internal Medicine
Volume	158
Issue number	12
DOIs	https://doi.org/10.7326/0003-4819-158-12-201306180-00003
Publication status	Published - 2013

Access to Document

10.7326/0003-4819-158-12-201306180-00003

Cite this

Mahaffey, K. W., Wojdyla, D., Hankey, G., White, H. D., Nessel, C. C., Piccini, J. P., Patel, M. R., Berkowitz, S. D., Becker, R. C., Halperin, J. L., Singer, D. E., Califf, R. M., Fox, K. A. A., Breithardt, G., & Hacke, W. (2013). Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy: A Subgroup Analysis of a Randomized Trial. Annals of Internal Medicine, 158(12), 861-868. https://doi.org/10.7326/0003-4819-158-12-201306180-00003

@article{902f7d32c61b4791ab193b43a2013483,

title = "Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy: A Subgroup Analysis of a Randomized Trial",

author = "K.W. Mahaffey and D. Wojdyla and Graeme Hankey and H.D. White and C.C. Nessel and J.P. Piccini and M.R. Patel and S.D. Berkowitz and R.C. Becker and J.L. Halperin and D.E. Singer and R.M. Califf and K.A.A. Fox and G. Breithardt and W. Hacke",

year = "2013",

doi = "10.7326/0003-4819-158-12-201306180-00003",

language = "English",

volume = "158",

pages = "861--868",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "12",

}

Mahaffey, KW, Wojdyla, D, Hankey, G, White, HD, Nessel, CC, Piccini, JP, Patel, MR, Berkowitz, SD, Becker, RC, Halperin, JL, Singer, DE, Califf, RM, Fox, KAA, Breithardt, G & Hacke, W 2013, 'Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy: A Subgroup Analysis of a Randomized Trial', Annals of Internal Medicine, vol. 158, no. 12, pp. 861-868. https://doi.org/10.7326/0003-4819-158-12-201306180-00003

TY - JOUR

T1 - Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy: A Subgroup Analysis of a Randomized Trial

AU - Mahaffey, K.W.

AU - Wojdyla, D.

AU - Hankey, Graeme

AU - White, H.D.

AU - Nessel, C.C.

AU - Piccini, J.P.

AU - Patel, M.R.

AU - Berkowitz, S.D.

AU - Becker, R.C.

AU - Halperin, J.L.

AU - Singer, D.E.

AU - Califf, R.M.

AU - Fox, K.A.A.

AU - Breithardt, G.

AU - Hacke, W.

PY - 2013

Y1 - 2013

U2 - 10.7326/0003-4819-158-12-201306180-00003

DO - 10.7326/0003-4819-158-12-201306180-00003

M3 - Article

C2 - 23778903

SN - 0003-4819

VL - 158

SP - 861

EP - 868

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 12

ER -